ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
10.30
-0.03 (-0.29%)
Oct 9, 2026, 10:56 AM EDT - Market open
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $2.31 billion as of October 9, 2026. It is the 6,154th most valuable company in the world and the 1,671st biggest in the United States. Its market cap has decreased by 33.87% in one year.
Market Cap
2.31B
Enterprise Value
2.37B
1-Year Change
-33.87%
Global Rank
Country Rank
#1,671 United States
Category
ChartMarket Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $2.31B, an increase of 4,495.70%. That is a compound annual growth rate of 34.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.31B | -46.86% |
| Dec 31, 2025 | 4.34B | 7.08% |
| Dec 31, 2024 | 4.05B | 296.92% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
| Oct 17, 2013 | 50.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 2.39B |
| Nurix Therapeutics | 2.37B |
| Disc Medicine | 2.35B |
| Recursion Pharmaceuticals | 2.34B |
| Harmony Biosciences Holdings | 2.30B |
| SELLAS Life Sciences Group | 2.28B |
| Pharvaris | 2.21B |
| Immunome | 2.19B |